Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (HIMS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
hims · stock forecast · 20 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 20 Wall Street analysts in the past 3 months
Hold
20 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$60.00
Consensus
$27.00
+0.5% upside
Low
$12.50
Median: $25 · Last Close: $26.86
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$27.00
0.5% upside
High Target
$60
123.4%
Low Target
$12.5
-53.5%
Current Price
$26.86
as of today
Based on analyst price targets, the HIMS stock price prediction for the next 12 months ranges from $12.5 to $60. The consensus HIMS price forecast of $27.00 implies 0.5% upside from the current price of $26.86.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $28.14 | ↑ 4.77% |
1-day model range: $27.89–$28.4. Peak: $28.4 (+4.77%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HIMS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | B of A Securities | Maintains | Neutral→Neutral |
| 2026-05-22 | Truist Securities | Maintains | Hold→Hold |
| 2026-05-19 | B of A Securities | Maintains | Neutral→Neutral |
| 2026-05-13 | B of A Securities | Maintains | Neutral→Neutral |
| 2026-05-12 | Citigroup | Maintains | Neutral→Neutral |
| 2026-05-12 | BTIG | Maintains | Neutral→Neutral |
| 2026-05-12 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-12 | Needham | Maintains | Buy→Buy |
| 2026-04-24 | B of A Securities | Maintains | Neutral→Neutral |
| 2026-04-16 | B of A Securities | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Hims & Hers Health, Inc. (HIMS) stock. Of the recent 122 rating actions, 9 were upgrades and 8 were downgrades. 20 analysts currently cover HIMS.
Analyst Recommendation Trends
HIMS analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2.9B
↓ 26.5% YoY
Revenue Next Year
$3.4B
↑ 19.0% YoY
EPS This Year
$-0.09
EPS Next Year
$0.47
↓ 609.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast HIMS EPS of $-0.09 for the current fiscal year, based on estimates from 8 analysts. The HIMS revenue forecast is $2.9B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HIMS stock forecast is supported by two independent data sources: analyst consensus ratings from 20 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HIMS price target is $27.00 (+0.5% upside), with an analyst consensus of Hold.
The HIMS short-term stock prediction for tomorrow is $28.14 (+4.77%).
Hims & Hers Health, Inc. trades on NYSE under the ticker HIMS. The HIMS stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 35% of covering analysts.
Frequently asked questions
HIMS forecast · 8 questionsAccording to 20 Wall Street analysts, the average 12-month HIMS price target is $27.00, with a high forecast of $60.00 and a low of $12.50. The median price target is shown in the chart above when available. This implies +0.5% potential upside from the current price of $26.86.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.